Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
tags : Europe entities : Amarin corporation plc save search
Amarin Provides Update on VAZKEPA® (Icosapent Ethyl) Intellectual Property Portfolio in EuropeCompany’s IP Protection for VAZKEPA® in Europe Now Extended Into 2039
Published: 2024-04-03 (Crawled : 19:00) - biospace.com/
AMRN | News | $0.8844 0.13% 0.12% 660K
|
Health Technology
|
| O: 3.03%
H: 8.82%
C: 3.92%
vazkepa europe update
Amarin Provides Update on VAZKEPA® (Icosapent Ethyl) Intellectual Property Portfolio in Europe
Published: 2024-04-03 (Crawled : 12:00) - globenewswire.com
AMRN | News | $0.8844 0.13% 0.12% 660K
|
Health Technology
|
| O: 3.03%
H: 8.82%
C: 3.92%
vazkepa europe update
Amarin Announces Vascepa® (Icosapent Ethyl) Approved to Reduce Cardiovascular Risk in the Kingdom of Saudi Arabia (KSA)
Published: 2023-06-21 (Crawled : 13:00) - biospace.com/
AMRN | News | $0.8844 0.13% 0.12% 660K
|
Health Technology
|
| O: -0.84%
H: 1.69%
C: -0.85%
vascepa approved risk cardiovascular
Amarin Corporation to Present New Data Evaluating VASCEPA®/VAZKEPA® (Icosapent Ethyl) at ACC.23/WCCPresentations on Additional REDUCE-IT® Sub-Population, In-Vitro Data on EPA to Be Featured at the Congress
Published: 2023-02-27 (Crawled : 16:00) - biospace.com/
AMRN | News | $0.8844 0.13% 0.12% 660K
|
Health Technology
|
| O: 1.69%
H: 3.61%
C: 2.22%
vascepa in-vitro corporation in vitro
Amarin to Present at Cowen's 43rd Annual Health Care Conference
Published: 2023-02-22 (Crawled : 14:00) - biospace.com/
AMRN | News | $0.8844 0.13% 0.12% 660K
|
Health Technology
|
| O: 1.67%
H: 0.27%
C: -0.55%
care conference health
Amarin Files Definitive Proxy Materials and Mails Letter to Shareholders
Published: 2023-01-31 (Crawled : 15:00) - biospace.com/
AMRN | News | $0.8844 0.13% 0.12% 660K
|
Health Technology
|
| O: 0.0%
H: 4.86%
C: 2.76%
Amarin to Report Second Quarter 2022 Financial Results and Host Conference Call on August 3, 2022
Published: 2022-07-20 (Crawled : 16:00) - biospace.com/
AMRN | News | $0.8844 0.13% 0.12% 660K
|
Health Technology
|
| O: 0.0%
H: 9.3%
C: 3.88%
conference report results
Amarin to Present at the 40th Annual J.P. Morgan Healthcare Conference
Published: 2022-01-04 (Crawled : 15:00) - biospace.com/
AMRN | News | $0.8844 0.13% 0.12% 660K
|
Health Technology
|
| O: 1.14%
H: 0.56%
C: -2.54%
health thc conference j.p. morgan healthcare conference
Amarin Announces First European Launch of VAZKEPA (icosapent ethyl) in Germany
Published: 2021-09-13 (Crawled : 13:00) - biospace.com/
AMRN | News | $0.8844 0.13% 0.12% 660K
|
Health Technology
|
| O: 0.19%
H: 2.07%
C: -0.75%
europe germany
Amarin Reports Overview of Latest Clinical Research Evaluating VASCEPA®/VAZKEPA (Icosapent Ethyl) and Eicosapentaenoic Acid (EPA) Presented at ESC Congress 2021, Organized by the European Society of Cardiology
Published: 2021-08-31 (Crawled : 12:00) - biospace.com/
AMRN | News | $0.8844 0.13% 0.12% 660K
|
Health Technology
|
| O: 0.0%
H: 2.44%
C: -1.81%
europe cardiology test vascepa research cardio
Amarin Reports Data from REDUCE-IT® Showing VASCEPA®/VAZKEPA (Icosapent Ethyl) Significantly Reduces Ischemic Events in Patients with Prior Heart Attacks Presented in Late Breaking Science Session at ESC Congress 2021, Organized by the European Society of Cardiology
Published: 2021-08-23 (Crawled : 08:00) - globenewswire.com
AMRN | News | $0.8844 0.13% 0.12% 660K
|
Health Technology
|
| O: 2.97%
H: 7.57%
C: 4.14%
heart europe cardiology vascepa cardio
Latest Clinical Research Evaluating VASCEPA®/VAZKEPA (Icosapent Ethyl) in Patients with Residual Cardiovascular Risk to be Presented at ESC Congress 2021, Organized by the European Society of Cardiology
Published: 2021-08-16 (Crawled : 12:00) - globenewswire.com
AMRN | News | $0.8844 0.13% 0.12% 660K
|
Health Technology
|
| O: -3.48%
H: 0.46%
C: -2.22%
europe risk cardiovascular cardiology test vascepa research cardio
Further Insights into Mechanism of Action of Icosapent Ethyl and Its Unique Form of Eicosapentaenoic Acid (EPA) Presented at the European Atherosclerosis Society (EAS) Congress 2021
Published: 2021-06-02 (Crawled : 21:00) - globenewswire.com
AMRN | News | $0.8844 0.13% 0.12% 660K
|
Health Technology
|
| O: -0.87%
H: 3.3%
C: 0.88%
europe unique sclerosis
Gainers vs Losers
| 65% | 35% |
Top 10 Gainers
CSSE 4 | $0.4323 183.85% 64.77% 210M
|
Consumer Services
BOF | $1.99 70.09% 41.21% 110M
|
ILAG | $0.51 6.03% 40.62% 1.7M
|
LICN | $0.941 68.04% 40.49% 15M
|
AMST | $3.31 65.5% 39.58% 70M
|
Technology Services
MTC | $3.615 61.38% 38.04% 9.3M
|
Technology Services
WIMI | $1.15 58.53% 36.92% 19M
|
Technology Services
AIH | $0.45 12.5% 30.92% 320K
|
Health Services
MULN | News | $3.78 38.46% 27.78% 13M
|
Information
RILY | $29.86 37.48% 27.26% 12M
|
Finance
Your saved searches
Save your searches and get alerts when important news are released.